Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px
Document › Details

GATC Biotech AG. (12/2/14). "Press Release: GATC Biotech Releases Future Oriented Portfolio Structure. Customer Will Benefit from Enhanced User Friendliness – Tripartition Facilitates a Clear and Intuitive Structure". Constance.

Organisations Organisation GATC Biotech AG, Customized Solutions division
  Today Eurofins Genomics Europe Sequencing GmbH
  Group Eurofins (Group)
  Organisation 2 GATC Biotech AG, Diagnostics division
  Today Eurofins Genomics Europe Sequencing GmbH
  Group Eurofins (Group)
Products Product DNA sequencing service
  Product 2 diagnostic services
Persons Person Pohl, Peter (GATC Biotech AG 200611 CEO)
  Person 2 Benz, Marcus (GATC Biotech 200706– COO joined GATC 2000 as Head Quality Management)

The Executive Board of GATC Biotech AG today introduced the new structure of its portfolio: Three operating divisions named Sequencing Solutions, Customized Solutions, and Diagnostic Solutions will build the solid base. This will give a far greater entrepreneurial independence, will allow a more targeted management of GATC Biotech’s respective businesses, positioning their solutions even closer to their markets as well as customers and will bring further improvements in efficiency. Further details of the new structure will be released during the coming months.

Peter Pohl, co-founder and CEO explained: "Through the reorganisation of the portfolio structure we will establish a better basis for a more differentiated management of our various businesses. This will increase our strategic flexibility and boost our leading competitive positions in different markets even better."

The business model for all three divisions is based on the provision of target-oriented and innovation-driven solutions. “We know that each research question is unique. So we try to address our customer’s needs in the most specific way.” added Peter Pohl.

Sequencing Solutions comprises our well-established Sanger sequencing services with our standardised and streamlined InViewTM products and is principally characterised by integrated technology platforms and utmost efficiency. The standardised products are complemented by the newly released modular NGSelectTM product line for GATC Biotech´s power user. For the majority of sequencing projects our standard solutions will meet all requirements.

Customized Solutions commits for individual projects - made-to-order for specific requirements not covered by standardised workflows.

Diagnostic Solutions targets for strong partnerships in the regulated market of human diagnostics. The ISO 17025 accredited 'Genome and Diagnostic Centre' offers individual approaches in translational medicine for the development of companion diagnostics and the progressing implementation of personalised medicine in oncology.

GATC Biotech will further increase efficiency and effectiveness in order to strengthen their competitive advantages. In the future, investments and, where appropriate, alliances should further concentrate on securing and extending its stable market positions.

“Our today’s strategy will be an unambiguous commitment to concentrate our efforts and resources on our priority areas of growth. I am confident that we made the right strategic decisions for continuous growth and to prove ourselves as innovative scientific leader. I’m equally confident that our GATC Team possesses the expertise, determination and focus to deliver for our customers as well as our partners.” added Dr. Marcus Benz, COO.


GATC Biotech, a family-owned business, is one of the world´s leading service provider of DNA and RNA sequencing. For over two decades, the company has offered sequencing and bioinformatics solutions from single samples up to large scale projects. During this time, GATC Biotech has developed to a renowned brand, not only mastering a broad range of technologies and related downstream data analysis, but also processing millions of customer samples in professional quality and ready for diagnostic purposes.

The company offers true multiplatform sequencing using all leading sequencing technologies in its own labs. Its headquarter in Constance, Germany houses its ISO 17025 certified 'Genome and Diagnostic Centre' with a focus on next and third generation sequencing. The European Custom Sequencing Centre located in Cologne, Germany focuses on GATC Biotech’s Sanger sequencing service. This advantageous location ensures rapid and efficient sample logistics. All laboratories have highly integrated and fully automated processing pipelines, ensuring full compliance with latest state-of-the-art quality standards.

Please visit for more information.

Record changed: 2017-04-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Eurofins (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top